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Xnot provided, although this would certainly be expected to
affect mortality rates. Also, the timing of the complication
in relation to the LTx is also not available in the dataset;
therefore, time zero could not be defined as the time of
the complication but rather had to be defined as the date
of the LTx.
A limitation of our statistical analysis is that center
volume is a dynamic variable that changes on an annual
basis. In other words, a center that may be low volume in
earlier years may become higher volume over time, or
vice versa. We chose to use aggregate volume to account
for these year-to-year changes. Despite this limitation, we
found that the average standard deviation for annual volume
within each individual center was only 6.2 LTx; further-
more, only 2 (2.6%) programs that had come online during
the study period would have been reclassified as their vol-
ume changed significantly over the study interval.
Additionally, aside from renal failure and stroke, compli-
cations were not uniformly coded throughout the study pe-
riod for each complication type. However, in the years that
the complications were available, the coding was relatively
complete for the majority of patients. Furthermore, inas-
much as there is variable length of hospital stay after LTx,
the ‘‘exposure’’ to developing early complications is also
variable between patients and between centers. We also
did not include quality of life data, although this is certainly
an important outcome in LTx and likely correlates with
rates of complications. A final limitation was that we could
not determinewhether patient mortality was related to a spe-
cific complication or not, and if so, to what degree. Al-
though coding is available for the cause of death in
patients in the UNOS dataset, the sequence of clinical
events leading to a patient’s death can be complex and the
etiology of death is often multifactorial. Therefore, a simple
code for 1 cause of death is often not convincing of whether
the death was in actuality related in any way to a specific
complication.CONCLUSIONS
In this review of over 12,000 patients with primary LTx,
we found that higher volume centers did not have signifi-
cantly lower rates of postoperative complications but were
best able to mitigate the adverse effects of these complica-
tions on both short- and long-term survival. These data
suggest that identifying and implementing the institutional
practices that lead to better management of postoperative
complications after LTx in high volume centers may be
prudent to improving outcomes in lower volume hospitals.References
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DrMatthewBacchetta (New York, NY). I thank the Association
for the opportunity to comment on this excellent paper and I thank
the authors and Dr Kilic for providing me a copy well in advance.
The theme of superiority of high volume centers versus low
volume centers with respect to quality of outcome is certainly
not new, yet it continues to expand over a range of operative pro-
cedures from the abdomen to the chest. The Johns Hopkins group
reported a similar paper in 2009 at the meeting of The Society of
Thoracic Surgeons about the value of high volume centers for im-
proved outcome. We have another paper here that suggests similar
conclusions, yet there are clearly some major differences in the
focus, analysis, observations, and conclusions. In essence, your
analysis found that postoperative complication rates were approx-
imately the same across all groups, suggesting that we have stan-
dardized our preoperative assessment of patients and standardized
our immunosuppression and surgical techniques, with only slight
institutional variability, which has led to uniform complication
rates across your groups, yet the short-term and long-term impact
of these complications was significantly influenced by center
volume. Your study suggests that anybody can build a car but
only a few know how to fix it when it breaks. Begging the question
is, are high volume centers better at fixing cars than low volume
centers simply because they have more service centers? They
have more staff, transplant pulmonologists, and so on. With that
in mind, I have a few technical questions and a few more policy-
oriented questions.gery c December 2012
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XThe paper from 2009 used 20 cases per year as the inflection
point for low and high volume. In your analysis you have come
up with 21.8. You chose to use tertiles as opposed to the quartiles
that were used in 2009. It seems a bit arbitrary. I hope that you will
delve into that a little bit. Is there a meaningful difference between
a center that is doing 20 transplants per year and one that’s doing
22? Why not analyze the outcomes of centers doing 5 or 10 or less
per year as ultra–low volume centers? Do you have any data that
might hint at that outcome of these ultra–low volume centers?
Is the difference in outcome borne from a deficit in staffing at
low volume centers, which can easily become overwhelmed
when a major postoperative complication occurs—anastomotic
leaks, primary graft dysfunction, renal failure, and so forth? At
our institution we have many transplant pulmonologists who are
dedicated to this, and it makes it easier to manage these types of
complications. Is it really simply a matter of staffing? There are
some low volume centers that have very good outcomes, as good
as high volume centers. How does your study address the issue
of what makes for a center of excellence in lung transplantation?
Can we use your study to implement changes in lung transplan-
tation that will improve national outcomes? Given that 35% of all
the lung transplants during your study period were done by low
volume centers, that is a big number and has huge policy implica-
tions and staffing implications. The hope of a lot of epidemiologic
studies is to provide some guidance for policy recommendations.
Should we conclude that lung transplantation should be restricted
to centers that do 22 transplants or more, or does this provide the
ground for regionalization?
Dr Kilic. Thank you, Dr Bacchetta, for those comments and
questions.
We modeled center volume both as a continuous variable,
where it was found to have significant impact at each of the
time points, as well as a categorical variable. Defining it according
to a categorical variable really was done so that we could plot
Kaplan-Meier analyses; otherwise, there is really no way to do
it when you have it as a continuous variable, and we thought
that the best way to do it would be to divide the centers into
equal-sized patient tertiles. We did not show the data here, but
if you plot annual center volume as a continuous variable and
look at mortality on the y-axis, the best discriminatory threshold
for survival is around 20, and that is with both uncomplicated
and complicated cases. I do think that is the optimal volume
threshold. Having said that, though, and this ties in with your
question about regionalization, although taken as a whole, the
high volume centers have improved outcomes, there is a cohort
of low volume centers that consistently have good outcomes every
year. I do not think this information is meant to penalize all the
low volume centers, but I think it does indicate that we need to
identify what the specific practices are in the high volume centers
so that we can translate them into the poorly performing low vol-
ume centers. In terms of what those practices may be specifically
relating to complications, if we talk about identifying complica-
tions early, I think it does have to do with staffing. Studies have
shown that nurse/patient ratios, for instance, or qualifications of
nurses have an important impact on identifying complications
and rescue from complication rates. In terms of managing the
complications once they are identified, I think availability ofThe Journal of Thoracic and Carconsult services, individual surgeon experience, and other cen-
ter-level factors would have an important impact. Perhaps another
important step would be to have UNOS and some of these other
registries start to collect institutional variables beyond volume
so that we can at least start to study them and see which ones
are important factors in contributing to outcomes.
Dr Thomas K. Waddell (Toronto, Ontario, Canada). I want to
ask about the statistics of the hazard ratio that you gave for later
time periods, 1 and 5 years. I understand the concept of failure
to rescue; somebody has a bad complication and you have to see
a lot of them in order to rescue them and pull them out of the in-
tensive care unit. I am unclear about the impact of early complica-
tions on 5-year mortality as a failure to rescue model. I do not quite
understand that. Did you actually model hazard function as 2 func-
tions, an early acute risk and a slower plateau phase kind of
hazard? If you did find that the plateau phase hazard was in fact
affected by center volume, what do you think is the medical equiv-
alent of failure to rescue in that situation?
Dr Kilic. Thank you for that question. We did actually look at
conditional survival as well. When you incorporate conditional
survival to 90 days, there is still an important center volume effect
beyond that to the 1-year and 5-year mark. I do agree that at 1 year
and 5 years, it is hard to delineate exactly how much of that is re-
lated to the complication versus other factors that may develop in
the longer term. Our analysis does not show the mortalities related
to these complications. It simply shows that in patients who have
a complication, the survival is better when they are at a higher
volume center, and we can presume that it may be related to that
complication. Renal failure, for instance, causes a dramatic de-
cline in survival. It is the worst of all the complications. We can
presume that it is due to that. However, again, this study was de-
signed for associative rather than causal relationships.
Dr Stephan Schueler (Newcastle upon Tyne, United Kingdom).
I come from a high volume lung transplant center. We do about 60
a year. The striking thing in your survival curves was actually the
fact that the 30-day drop in survival was identical among all the
centers. You would expect that this early attrition rate would be
much less in high volume centers, that is, the experienced centers,
because of their better judgment. Based on early or bad experience,
they should have better judgment in terms of picking the better
donor and managing the patients better. My second question is,
would your chest physicians now refer patients to high volume
centers according to your data?
Dr Kilic. To answer the first question, the effect was actually
the strongest in the short term. If you look at the hazard ratios in
the risk-adjusted analysis, the hazard ratio is actually the highest
at the 90-day mark and then weans down from there into the
1-year and 5-year marks. The effect is exactly what you are saying.
It is actually the greatest in the short term and then reduces in the
longer term.
To answer your second question, again, I do not think this infor-
mation is meant to say that we should regionalize all lung trans-
plants to high volume centers, inasmuch as some low volume
centers perform well. I think it just says that we need to do more
research to identify exactly why these volume-outcome relation-
ships exist and what we can do to implement those practices in
poorly performing low volume centers.diovascular Surgery c Volume 144, Number 6 1509
